HEALIOS K.K. (4593.T) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	74.0M	104.0M	560.0M	121.0M	90.0M
Cost of Revenue	—	218.0M	128.0M	13.0M	—
Gross Profit	8.0M	(114.0M)	432.0M	109.0M	90.0M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	354.0M	1.3B	1.4B	1.2B	1.4B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	7.0M	6.0M	—	2.0M	22.0M
Total Operating Expenses	361.0M	1.3B	1.4B	1.2B	1.5B
Cost and Expenses	3.8B	3.4B	3.4B	3.5B	5.3B
Operating Income (EBIT)	(3.7B)	(3.3B)	(2.8B)	(3.4B)	(5.2B)
Non-Operating
Interest Income	326.0M	1.4B	373.0M	456.0M	346.0M
Interest Expense	2.7B	200.0M	1.6B	704.0M	500.0M
Net Interest Income	(2.3B)	1.2B	(1.2B)	(248.0M)	(154.0M)
Other Non-Op Income/Expense	21.0M	69.0M	60.0M	2.0M	10.0M
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	(3.5B)	(2.1B)	(4.1B)	(3.6B)	(5.3B)
Income Tax Expense	(7.0M)	103.0M	166.0M	187.0M	(160.0M)
Bottom Line
Net Income	(3.1B)	(2.2B)	(4.2B)	(3.8B)	(5.2B)
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(3.1B)	(2.2B)	(4.2B)	(3.8B)	(5.2B)
Per Share
Basic EPS	(¥26)	(¥21)	(¥48)	(¥56)	(¥91)
Diluted EPS	(¥26)	(¥27)	(¥48)	(¥56)	(¥91)
Revenue Per Share	¥1	¥1	¥6	¥2	¥2
Shares
Basic Shares Outstanding	125.8M	107.7M	88.5M	68.0M	57.0M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	(1.1B)	(3.1B)	(2.5B)	(3.2B)	(4.8B)
D&A	70.0M	275.0M	297.0M	224.0M	386.0M
EBIT	(3.7B)	(3.3B)	(2.8B)	(3.4B)	(5.2B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026